Skip to content

13F-HR filed by JW Asset Management, LLC

JW Asset Management, LLC filed this 13F-HR for the quarter ended 2014-12-31, filed 2015-02-05, with 57 holding rows worth $133,223,000.

Accession
0001420506-15-000047
Filed
2015-02-05
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2014

A holdings report, 116 entries on the cover page, a total value of $133,223,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $133,223,000 with VALUE read as thousands by filing date, 13F file number 028-16404. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
TARO PHARMACEUTICAL INDS LTDM8737E108SHS106,931$15,846,000thousands by filing date
REGENERON PHARMACEUTICALS COM75886F107Stock36,355$14,915,000thousands by filing date
Tesla Motors, Inc88160R101COM55,145$12,265,000thousands by filing date
BLACKSTONE GROUP LP09253U108COM UNIT LTD265,860$8,994,000thousands by filing date
ACTAVIS PLCG0083B108SHS34,526$8,888,000thousands by filing date
FLAMEL TECHNOLOGIES-SP ADR338488109SPON495,154$8,482,000thousands by filing date
INSYS THERAPEUTICS INC45824V209COMMON STOCK191,027$8,054,000thousands by filing date
HORIZON PHARMA PLCG4617B105SHS580,684$7,485,000thousands by filing date
LANNETT COMPANY INCORPORATED516012101COM116,993$5,017,000thousands by filing date
JAZZ PHARMACEUTICALS PLC SHS USDG50871105Stock28,617$4,685,000thousands by filing date
ALEXION PHARMACEUTICALS INC015351109COM24,208$4,479,000thousands by filing date
PERRIGO CO PLC SHSG97822103Stock25,165$4,207,000thousands by filing date
SAGENT PHARMACEUTICALS INC786692103COM103,483$2,599,000thousands by filing date
COLUMBIA LABS INC197779200COM NEW405,356$2,270,000thousands by filing date
BUFFALO WILD WINGS INC119848109COMMON STOCK12,497$2,254,000thousands by filing date
AKORN INC009728106COM50,515$1,829,000thousands by filing date
LIGAND PHARMACEUTICALS INC53220K504COM NEW32,727$1,741,000thousands by filing date
Amazon.com, Inc023135106COM5,171$1,605,000thousands by filing date
EAGLE PHARMACEUTICALS INC269796108COM101,823$1,578,000thousands by filing date
CHIPOTLEMEXICANGRILLI169656105STOK2,046$1,401,000thousands by filing date
BIOGEN INC COM09062X103Stock3,869$1,313,000thousands by filing date
ANI PHARMACEUTICALS INC00182C103COM22,524$1,270,000thousands by filing date
Mallinckrodt PlcG5785G107SHS10,964$1,086,000thousands by filing date
PERNIX THERAPEUTICS HOLDINGS71426V108COM112,160$1,054,000thousands by filing date
SALIX PHARMACEUTICALS INC795435106COM9,040$1,039,000thousands by filing date
IGI LABORATORIES INC449575109COM113,740$1,001,000thousands by filing date
VANDA PHARMACEUTICALS INC921659108COM67,746$971,000thousands by filing date
SHIRE PLC82481R106COMMON STOCK-FO4,172$887,000thousands by filing date
ENDO INTL PLCG30401106SHS11,998$865,000thousands by filing date
IMPAX LABORATORIES INC45256B101COM26,034$825,000thousands by filing date
MICHAEL KORS HLDGS LTDG60754101SHS9,510$714,000thousands by filing date
Netflix, Inc64110L106COM1,377$470,000thousands by filing date
DIGIRAD CORP253827109COM102,466$447,000thousands by filing date
ALLERGAN INC018490102COM2,032$432,000thousands by filing date
PRICELINE GRP INC741503403COM NEW300$342,000thousands by filing date
RETROPHIN INC761299106COM16,459$202,000thousands by filing date
ALIBABA GROUP HLDG LTD01609W102SPONSORED ADS1,524$158,000thousands by filing date
PROGENICS PHARMACEUTICALS IN743187106COM20,540$156,000thousands by filing date
MEDICAL TRANSCRIPTION BLG CO58464J105COM63,667$149,000thousands by filing date
ARIAD PHARMACEUTICALS INC04033A100COM21,612$148,000thousands by filing date
CTI BIOPHARMA CORP COM NEW12648L106Stock52,271$123,000thousands by filing date
POZEN INC73941U102COMMON STOCK14,653$117,000thousands by filing date
ENERGOUS CORP29272C103COM10,000$110,000thousands by filing date
ANTARES PHARMA INC036642106COM41,936$108,000thousands by filing date
GERON CORP374163103COM30,000$98,000thousands by filing date
SAREPTA THERAPEUTICS INC803607100COM6,000$87,000thousands by filing date
SECOND SIGHT MED PRODS INC81362J100COM8,500$87,000thousands by filing date
INTERCEPT PHARMACEUTICALS IN45845P108COM522$81,000thousands by filing date
CAMBREX CORP132011107COM2,324$51,000thousands by filing date
PDI INC69329V100COM28,222$51,000thousands by filing date
QLT INC746927102COMMON STOCK10,993$44,000thousands by filing date
ROCKWELL MED INC774374102COM4,200$43,000thousands by filing date
HERON THERAPEUTICS INC427746102COM3,275$33,000thousands by filing date
SENOMYX INC81724Q107COM5,108$31,000thousands by filing date
NANOSPHERE INC63009F105COM76,995$30,000thousands by filing date
ASTERIAS BIOTHERAPEUTICS INC04624N107COM SER A1,250$4,000thousands by filing date
BIOTIME INC09066L162W EXP 10/01/2011,529$2,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001420506-15-000047this filing2015-02-05acceptance time not in the bulk data set